Company intelligence / Profile preview

RxBiologics

Cambridge, Cambridgeshire, United Kingdom

Ownership: Private
Employees: ~15
Development stage: Other

Overview

RxBiologics offers antibody discovery services based on its proprietary Galaxy® library platform, which has repeatedly delivered clinic-ready antibody clones straight from the library, enabling rapid progression to preclinical development. The company has demonstrated strong revenue growth (>50% projected in 2025), but does not appear to have clinical candidates of its own; its work is primarily as a service provider for partners and clients.[1][3][4][5]

Modalities: Monoclonal antibodyBiologic
Industry: Drug Discovery Services

Partnerships

Clients and partners using Galaxy antibody library platform

Beyond the preview

Go deeper on RxBiologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RxBiologics.

Explore the full profile